ArticlePharmaceuticals (Basel, Switzerland)2024

Repurposing of c-MET Inhibitor Tivantinib Inhibits Pediatric Neuroblastoma Cellular Growth.

Rameswari Chilamakuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.